Canada's Drug Agency says new Alzheimer's drug should not be publicly funded
· Ottawa Citizen
A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher. Read More
Visit xsportfeed.quest for more information.